Paper3319640
Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
Naukkarinen VA and 2 others. Eur J Clin Pharmacol, 1987. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension. Papers, record 3319640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3319640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Nicardipine | Major topic |
| Propranolol | Major topic |
| Adult | |
| Blood Pressure | |
| Body Weight | |
| Cholesterol | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Humans | |
| Lipids | |
| Lipoproteins | |
| Middle Aged | |
| Random Allocation | |
| Triglycerides |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6831117 | Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6831117 | PubMed |
| 2 | 3907322 | Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3907322 | PubMed |
| 3 | 4027149 | The metabolism and pharmacokinetics of nicardipine hydrochloride in man. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027149 | PubMed |
| 4 | 4027151 | Noninvasive assessment of the haemodynamic effects of nicardipine in normotensive subjects. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027151 | PubMed |
| 5 | 3976506 | Coronary and systemic hemodynamic effects of nicardipine. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3976506 | PubMed |
| 6 | 7406961 | Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93. | Clin Exp Pharmacol Physiol | 1980 | https://conductscience.org/library/papers/7406961 | PubMed |
| 7 | 3460970 | The effect of nifedipine on plasma lipids in patients with essential hypertension. | Int J Clin Pharmacol Ther Toxicol | 1986 | https://conductscience.org/library/papers/3460970 | PubMed |
| 8 | 6104255 | Effect of propranolol and prazosin on blood lipids. The Oslo Study. | Lancet | 1980 | https://conductscience.org/library/papers/6104255 | PubMed |
| 9 | 7050440 | Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. | JAMA | 1982 | https://conductscience.org/library/papers/7050440 | PubMed |
| 10 | 7001898 | Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. | Am J Med | 1980 | https://conductscience.org/library/papers/7001898 | PubMed |
| 11 | 6292718 | Mechanism of action of calcium-channel-blocking agents. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6292718 | PubMed |
| 12 | 3880997 | Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3880997 | PubMed |
| 13 | 3896278 | Nicardipine hydrochloride in essential hypertension--a controlled study. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3896278 | PubMed |
| 14 | 6692656 | Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. | Clin Sci (Lond) | 1984 | https://conductscience.org/library/papers/6692656 | PubMed |
| 15 | 2861880 | MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/2861880 | PubMed |
| 16 | 2857516 | Calcium-entry blocking agents in the treatment of systemic hypertension. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/2857516 | PubMed |
| 17 | 6177968 | Relation of blood pressure response to therapy and the occurrence of myocardial infarction and stroke. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6177968 | PubMed |
| 18 | 2860883 | Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. | Arch Intern Med | 1985 | https://conductscience.org/library/papers/2860883 | PubMed |
| 19 | 7104159 | Effect of pindolol on serum lipids and lipid metabolizing enzymes. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104159 | PubMed |
| 20 | 6177959 | The emerging problem of plasma lipid changes during antihypertensive therapy. | J Cardiovasc Pharmacol | 1982 | https://conductscience.org/library/papers/6177959 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3319640
GET https://conductscience.org/api/papers/v1/3319640/references?page=2